Dec. 12, 2019 Price forecast | 2 weeks: -2.60% | 1 month: -8.76% | 3 months: -11.05%


NVLNF stock forecast

Our latest prediction for Novelion Therapeutics, Inc.'s stock price was made on the Dec. 12, 2019 when the stock price was at 0.68$.

In the short term (2weeks), NVLNF's stock price should underperform the market by -2.60%. During that period the price should oscillate between -11.22% and +14.90%.

In the medium term (3months), NVLNF's stock price should underperform the market by -11.05%. During that period the price should oscillate between -26.97% and +41.14%.


About Novelion Therapeutics, Inc.

Novelion Therapeutics, Inc. engages in the development and commercialization of pharmaceuitical products. It focuses in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and is headquartered in Vancouver, Canada.

At the moment the company generates 135M USD in revenues.

On its last earning announcement, the company reported a loss of -5.67$ per share.

The book value per share is -6.06$

Novelion Therapeutics, Inc. website


Three months stock forecastDec. 12, 2019


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
135M 54.60% -42M -31.40% -107M -5.67 - - 19M -6.06 -25M - -25M